Use of coercive measure: use of seclusion room (time, days) · aggressive behaviour in schizophrenia
Structured risk assessment showed no clear difference in use of coercive measure: use of seclusion room (time, days) compared with standard professional care (low certainty).
1 finding from 1 review
Days in hospital · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service use: number of days in psychiatric hospital (assessed by mean number of days in hospital at end of treatment) · recent‐onset psychosis
1 finding from 1 review
Service use: number of days in psychiatric hospital (assessed by mean number of days in hospital at end of treatment) · recent‐onset psychosis (less than three years since the start of psychotic symptoms and either first or second psychotic episode)
1 finding from 1 review
Service use: 1. Average number of days in hospital per month ‐ by about 24 months · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health service outcomes: 2. Hospital bed‐days by 12 months · people with schizophrenia or other serious mental illness
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service utilisation outcomes: hospital admission or days in hospital · schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health service outcomes: 5. Days in community to first admission by 12 months · people with severe mental disorders
1 finding from 1 review
Service use: 1. Average number of days in hospital per month ‐ by about 24 months · people with severe mental disorders
1 finding from 1 review
Health service outcomes: 2. Hospital bed‐days by 12 months · people with severe mental disorders
1 finding from 1 review
Service utilisation outcomes: hospital admission or days in hospital · people with treatment‐resistant schizophrenia
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Service utilisation outcomes: hospital admission or days in hospital · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service utilisation outcomes: hospital admission or days in hospital · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service utilisation outcomes: hospital admission or days in hospital · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service utilisation outcomes: hospital admission or days in hospital · people with treatment‐resistant schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Service use: 1. Average number of days in hospital per month ‐ by about 24 months · people with severe mental disorders
1 finding from 1 review
Social functioning 2. Employment status ‐ by medium term ‐ spent > 1 day employed · people with severe mental disorders
It is very uncertain whether intensive Case Management changes social functioning 2. Employment status ‐ by medium term ‐ spent > 1… compared with non‐Intensive Case Management (very low certainty).
1 finding from 1 review
Service use: 1. Average number of days in hospital per month ‐ by about 24 months · people with severe mental disorders
1 finding from 1 review
Specific behaviour ‐ agitation · patients with psychosis‐induced aggression or agitation
1 finding from 1 review
Adverse effects: Specific ‐ dystonia between 0‐3 days (IM phase) · patients to psychosis‐induced aggression or agitation
It is very uncertain whether HALOPERIDOL changes adverse effects: Specific ‐ dystonia between 0‐3 days (IM phase) compared with OTHER ANTIPSYCHOTIC: d. LOXAPINE (very low certainty).
1 finding from 1 review